JP2025507894A5 - - Google Patents

Info

Publication number
JP2025507894A5
JP2025507894A5 JP2024552144A JP2024552144A JP2025507894A5 JP 2025507894 A5 JP2025507894 A5 JP 2025507894A5 JP 2024552144 A JP2024552144 A JP 2024552144A JP 2024552144 A JP2024552144 A JP 2024552144A JP 2025507894 A5 JP2025507894 A5 JP 2025507894A5
Authority
JP
Japan
Prior art keywords
item
mrna sequence
independently
motif
ivt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024552144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507894A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/014183 external-priority patent/WO2023167880A2/en
Publication of JP2025507894A publication Critical patent/JP2025507894A/ja
Publication of JP2025507894A5 publication Critical patent/JP2025507894A5/ja
Pending legal-status Critical Current

Links

JP2024552144A 2022-03-01 2023-02-28 Rnaをキャッピングするための組成物及び方法 Pending JP2025507894A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263315323P 2022-03-01 2022-03-01
US63/315,323 2022-03-01
US202363485753P 2023-02-17 2023-02-17
US63/485,753 2023-02-17
PCT/US2023/014183 WO2023167880A2 (en) 2022-03-01 2023-02-28 Compositions and methods for capping rnas

Publications (2)

Publication Number Publication Date
JP2025507894A JP2025507894A (ja) 2025-03-21
JP2025507894A5 true JP2025507894A5 (enExample) 2026-03-10

Family

ID=87884204

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024552144A Pending JP2025507894A (ja) 2022-03-01 2023-02-28 Rnaをキャッピングするための組成物及び方法

Country Status (5)

Country Link
US (1) US20250084409A1 (enExample)
EP (1) EP4486355A4 (enExample)
JP (1) JP2025507894A (enExample)
CN (1) CN119137271A (enExample)
WO (1) WO2023167880A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121311491A (zh) * 2023-06-26 2026-01-09 埃洛诺瓦株式会社 新型修饰三核苷酸加帽衍生物以及引入加帽衍生物的mRNA
WO2025054401A2 (en) * 2023-09-06 2025-03-13 Trilink Biotechnologies, Llc Cap analogs and methods of use thereof
CN116987137B (zh) * 2023-09-26 2024-01-02 江苏申基生物科技有限公司 一种加帽化合物及其在mRNA加帽中的应用
WO2025168058A1 (zh) * 2024-02-08 2025-08-14 江苏申基生物科技有限公司 新的mRNA加帽化合物及其应用
WO2026009929A1 (ja) * 2024-07-03 2026-01-08 富士フイルム株式会社 化合物、rna合成開始剤、およびそれらの利用
CN119306779A (zh) * 2024-12-13 2025-01-14 上海科泽永欣生物科技有限公司 一种含r构型的起始加帽寡核苷酸引物及其合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120842296A (zh) * 2015-09-21 2025-10-28 垂林克生物技术有限公司 用于合成5’-加帽rna的组合物和方法
WO2017066797A1 (en) * 2015-10-16 2017-04-20 Modernatx, Inc. Trinucleotide mrna cap analogs
ES2763822T3 (es) * 2015-12-09 2020-06-01 Novartis Ag Análisis exento de marcas de la eficacia de la adición de caperuzas al arn utilizando rnasa h, sondas y cromatografía líquida/espectrometría de masas
PL415967A1 (pl) * 2016-01-29 2017-07-31 Univ Warszawski 5'-tiofosforanowe analogi końca 5' mRNA (kapu), sposób ich otrzymywania i zastosowanie
US10487105B2 (en) * 2016-10-19 2019-11-26 Arcturus Therapeutics, Inc. Trinucleotide MRNA cap analogs
KR20200143391A (ko) * 2018-03-15 2020-12-23 비온테크 알엔에이 파마슈티컬스 게엠베하 5'-캡-트리뉴클레오티드- 또는 고차의 올리고뉴클레오티드 화합물 및 이들의 rna 안정화, 단백질 발현 및 치료에서의 사용
PL432884A1 (pl) * 2020-02-12 2021-08-16 Uniwersytet Warszawski Nowe analogi kapu końca 5' mRNA, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA i peptydu
PL248416B1 (pl) * 2020-02-12 2025-12-08 Explorna Therapeutics Spolka Z Ograniczona Odpowiedzialnoscia Nowe analogi kapu końca 5’ mRNA, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA i peptydu
EP4208549A4 (en) * 2020-09-04 2025-04-16 Verve Therapeutics, Inc. Compositions and methods for capping RNAs
US20250108066A1 (en) * 2022-01-27 2025-04-03 Trilink Biotechnologies, Llc Trinucleotide cap analogs and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2023540562A5 (enExample)
JP2025507894A5 (enExample)
JP7594563B2 (ja) 5’キャップ付rnaを合成するための組成物および方法
US9487544B2 (en) Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
EP1913011B1 (en) Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
EP2915815B1 (en) New modified nucleic acid
US20020055483A1 (en) 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatites virus infections
JPH08508493A (ja) 7−デアザプリン修飾オリゴヌクレオチド
CA2904692A1 (en) Modified 4'-nucleosides as antiviral agents
CN117940441A (zh) mRNA帽类似物和其用途
WO1991019713A1 (fr) Derive de nucleoside de pyrimidine
KR20200019127A (ko) 변형 핵산 단량체 화합물 및 올리고핵산 유사체
US12421272B2 (en) Artificial nucleic acid, production method therefor, and use thereof
US20200172563A1 (en) Photoresponsive nucleotide analog capable of photocrosslinking in visible light region
JPH07502740A (ja) 治療用ヌクレオシド
JP7725490B2 (ja) 新規人工核酸、その製造方法及び用途
WO2024002007A1 (zh) 含有可降低脱靶毒性的核苷酸类似物的双链rna
JP7723848B2 (ja) mRNAキャップ類似体及びその用途
US6914052B2 (en) Selective anti-viral nucleoside chain terminators
KR20230123318A (ko) 5'-캡핑된 rna 합성용 올리고뉴클레오티드
CA3253482C (en) Mrna cap analog and uses thereof
AU2024351425C1 (en) Mrna cap analog and use thereof
CA3253482A1 (en) Mrna cap analog and uses thereof
HK40080484A (en) Method for synthesizing 5'-capped rnas
CN118974071A (zh) mRNA帽类似物及其用途